Five-Year Outcomes of Sleeve Gastrectomy in Patients with Class I Obesity and Type 2 Diabetes Mellitus

[1] Jackson HT(2019)The role of bariatric surgery on diabetes and diabetic care compliance Curr Diab Rep 19 1-9

[2] Anekwe C(2015)Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab 19 563-23

[3] Chang J(2016)Impact of sleeve gastrectomy on type 2 diabetes mellitus, gastric emptying time, glucagon-like peptide 1 (GLP-1), Ghrelin and leptin in non-morbidly obese subjects with BMI 30–35.0 kg/m2: a prospective study Obes Surg 26 2817-481

[4] Haskins IN(2005)Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study Obes Surg 15 474-716

[5] Stanford FC(2019)Sustained improvements in glucose metabolism late after Roux-En-Y gastric bypass Surgery in Patients with and Without Preoperative Diabetes Sci Rep 9 15154-1320

[6] Singh AK(2008)Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 706-2352

[7] Singh R(2009)Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29 Surg Endosc 23 1313-50

[8] Kota SK(2018)Which bariatric procedure is the most popular in the world? A bibliometric comparison Obes Surg 28 2339-24

[9] Vigneshwaran B(2021)Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30-34.9 kg/m2 versus BMI < 30 kg/m2 Surg Endosc 35 1544-669

[10] Wahal A(2012)Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment Surg Obes Relat Dis 8 20-536

[1] Jackson HT(2019)The role of bariatric surgery on diabetes and diabetic care compliance Curr Diab Rep 19 1-9

[2] Anekwe C(2015)Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab 19 563-23

[3] Chang J(2016)Impact of sleeve gastrectomy on type 2 diabetes mellitus, gastric emptying time, glucagon-like peptide 1 (GLP-1), Ghrelin and leptin in non-morbidly obese subjects with BMI 30–35.0 kg/m2: a prospective study Obes Surg 26 2817-481

[4] Haskins IN(2005)Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study Obes Surg 15 474-716

[5] Stanford FC(2019)Sustained improvements in glucose metabolism late after Roux-En-Y gastric bypass Surgery in Patients with and Without Preoperative Diabetes Sci Rep 9 15154-1320

[6] Singh AK(2008)Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 706-2352

[7] Singh R(2009)Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29 Surg Endosc 23 1313-50

[8] Kota SK(2018)Which bariatric procedure is the most popular in the world? A bibliometric comparison Obes Surg 28 2339-24

[9] Vigneshwaran B(2021)Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30-34.9 kg/m2 versus BMI < 30 kg/m2 Surg Endosc 35 1544-669

[10] Wahal A(2012)Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment Surg Obes Relat Dis 8 20-536